This brand name is authorized in Estonia, Lithuania.
The drug TYPHERIX contains one active pharmaceutical ingredient (API):
1
|
UNII
7194H8W3KT - SALMONELLA TYPHI TY2 VI POLYSACCHARIDE ANTIGEN
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| J07AP | Typhoid vaccines | J Antiinfectives for systemic use → J07 Vaccines → J07A Bacterial vaccines |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| EE | Ravimiamet | 1045189, 1064641, 1064652, 1064663 |
| LT | Valstybinė vaistų kontrolės tarnyba | 1008027, 1015517, 1061826, 1061827 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.